Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β
Open Access
- 15 August 2003
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 17 (13) , 1-24
- https://doi.org/10.1096/fj.03-0084fje
Abstract
Type 1 plasminogen activator inhibitor (PAI-1) is the primary inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). Whereas PAI-1 is not expressed in no...Keywords
This publication has 29 references indexed in Scilit:
- PAI-1 deficiency attenuates the fibrogenic response to ureteral obstructionKidney International, 2001
- t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritisKidney International, 2001
- Amelioration of collagen-induced arthritis by thrombin inhibitionJournal of Clinical Investigation, 2001
- Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesisKidney International, 2000
- Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) miceNature, 1994
- Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.Journal of Clinical Investigation, 1993
- Growth factor control of extracellular proteolysisCell Differentiation and Development, 1990
- Thrombin regulates components of the fibrinolytic system in human mesangial cellsKidney International, 1990
- PARTICIPATION OF CELL-MEDIATED IMMUNITY IN DEPOSITION OF FIBRIN IN GLOMERULONEPHRITISThe Lancet, 1988
- Nephritogenicity of proteoglycans. II. A model of immune complex nephritisKidney International, 1988